Scientific evidence on the effectiveness of the Planmeca Ultra Low Dose™ imaging protocol
A new scientific study on Planmeca Ultra Low Dose™ by Ludlow and Koivisto establishes that the low dose imaging protocol enables CBCT imaging with a significantly lower dose than standard imaging, without a statistical reduction in image quality. The study’s conclusion states as follows:
“An average reduction in dose of 77% was achieved using ULD protocols when compared with standard protocols. While this dose reduction was significant, no statistical reduction in image quality between ULD and standard protocols was seen. This would suggest that patient doses can be reduced without loss